Bruker Toxtyper

Significance of the topic

Rapid and reliable detection of drugs, toxins and emerging psychoactive substances is critical in forensic and clinical environments. Laboratories face growing demands for high-throughput workflows, minimal false positives, and the flexibility to incorporate new compounds without extensive method redevelopment. A streamlined LC-MSn solution addresses these challenges by combining speed, confidence and ease of operation.

Objectives and Overview

This article presents the Toxtyper system, a push-button toxicology screening platform that integrates full-scan MSn library searching with automated data processing. The aim is to deliver qualitative screening, confirmation and semi-quantitation in a single, <12-minute analysis, supporting matrices such as blood, urine, plasma and oral fluid.

Methodology and Instrumentation

The analytical workflow relies on ultra-high-performance liquid chromatography coupled to sequential mass spectrometry (UHPLC-MSn) with patented Bruker technologies. Key features include:

• UHPLC separation using a robust, tune-free LC gradient suitable for basic, acidic and neutral compounds.
• Data-dependent acquisition of MS, MS2 and MS3 spectra with SmartFrag technology for reproducible fragmentation.
• Dual Ion Funnel and Zero Delay Alternating polarity switching to maximize sensitivity and detect a broad range of analytes in one run.
• Comprehensive, manually curated full-scan spectral library of nearly 1 200 compounds, with the option to import targeted sublibraries or user-defined entries.
• Fully automated data processing: spectral library search, result review, semi-quantification via one-point calibration, and PDF reporting.

Main Results and Discussion

Performance evaluations demonstrate:

• Analysis time of less than 12 minutes from injection to report.
• Limits of detection as low as 0.8 ng/mL for compounds such as fentanyl and buprenorphine in urine.
• Simultaneous detection of over ten analytes in a single sample following simple liquid–liquid extraction.
• Highly reproducible MS2/MS3 spectra across multiple instruments, ensuring consistent library search outcomes and low false-positive rates.
• Successful semi-quantitative assessment with a single calibration point and internal standards.

Practical Benefits and Applications

The Toxtyper platform offers:

• Minimal user training and 24/7 operation via an intuitive software interface designed for non-MS experts.
• Push-button sample submission, interactive review with color-coded results and chromatography/spectra overlays.
• Flexible library management, enabling rapid inclusion of new psychoactive substances (NPS) and targeted compound panels for enhanced sensitivity.
• Streamlined sample preparation without mandatory hydrolysis or derivatization, particularly beneficial for urine analysis.
• Combined screening and confirmation in a single run, reducing total instrument time and operational costs.

Future Trends and Opportunities

Advances and potential developments include:

• Expansion of spectral libraries through community contributions and automated curation for novel NPS.
• Integration of advanced quantitation algorithms to move from semi-quantitative to fully quantitative workflows.
• Enhanced data analytics and machine learning approaches for pattern recognition and predictive toxicology screening.
• Adaptation of the platform to additional matrices and sample types, such as tissue homogenates or environmental samples.

Conclusion

The Toxtyper system delivers a reliable, high-throughput solution for comprehensive toxicology screening. By combining fast UHPLC-MSn analysis, robust spectral libraries and intuitive software, laboratories can achieve confident identifications, semi-quantitative estimates and rapid turnaround, meeting the evolving demands of forensic and clinical research.

References

• Maurer/Wissenbach/Weber LC-MSn Library of Drugs, Poisons and Their Metabolites, 2nd Edition; ISBN: 978-3-527-34649.